Insiders · Profile

BOBULSKY SUSAN

Chief Commercial Officer, MRD at Adaptive Biotechnologies. Filing since 29 Sep 2020. CIK 0001820885

Company

Date

Role

Action

Shares

Amount

Of holding

ADPT Adaptive Biotechnologies Corp

6 Oct 2026

Chief Commercial Officer, MRD

Sold on a plan

6,444

$193.32K

1.6%

ADPT Adaptive Biotechnologies Corp

15 Sep 2026

Chief Commercial Officer, MRD

Sold on a plan

1,195

$32.27K

0.3%

ADPT Adaptive Biotechnologies Corp

10 Aug 2026

Chief Commercial Officer, MRD

Sold on a plan

3,000

$75.00K

0.8%

ADPT Adaptive Biotechnologies Corp

30 Jul 2026

Chief Commercial Officer, MRD

Sold on a plan

1,299

$31.18K

0.3%

ADPT Adaptive Biotechnologies Corp

16 Jul 2026

Chief Commercial Officer, MRD

Sold on a plan

5,000

$115.00K

1.2%

ADPT Adaptive Biotechnologies Corp

1 Jul 2026

Chief Commercial Officer, MRD

Sold on a plan

487

$10.71K

0.1%

ADPT Adaptive Biotechnologies Corp

25 Jun 2026

Chief Commercial Officer, MRD

Sold on a plan

5,000

$102.50K

1.2%

ADPT Adaptive Biotechnologies Corp

11 Jun 2026

Chief Commercial Officer, MRD

Sold on a plan

5,000

$95.00K

1.2%

ADPT Adaptive Biotechnologies Corp

4 Jun 2026

Chief Commercial Officer, MRD

Sold on a plan

11,000

$198.00K

2.6%

ADPT Adaptive Biotechnologies Corp

11 Mar 2026

Chief Commercial Officer, MRD

Sold at will

41,338

$544.42K

8.8%

ADPT Adaptive Biotechnologies Corp

5 Mar 2025

Chief Commercial Officer, MRD

Sold at will

26,023

$181.64K

7.0%

ADPT Adaptive Biotechnologies Corp

5 Mar 2024

Chief Commercial Officer, MRD

Sold at will

12,991

$44.63K

5.0%

ADPT Adaptive Biotechnologies Corp

10 Dec 2020

SVP, Diagnostics, clonoSEQ

Sold, plan not stated

25,000

$1.38M

100%

ADPT Adaptive Biotechnologies Corp

29 Sep 2020

SVP, Diagnostics, clonoSEQ

Sold, plan not stated

10,000

$500.00K

100%

14 decisions on file.